Skip to content

GRAIL, Inc. GRAL Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B0.0%
Guardant Health logo
Guardant HealthGH
131.3M+6.0%
Natera, Inc. logo
Natera, Inc.NTRA
141.5M+5.0%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
179M+5.0%
Immunome logo
ImmunomeIMNM
113.1M+42.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
155.5M+4.2%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s shares (diluted)?
GRAIL, Inc. (GRAL) reported shares (diluted) of 40.6M in Q1 2026.
How has GRAIL, Inc.'s shares (diluted) changed year-over-year?
GRAIL, Inc.'s shares (diluted) increased by 18.5% year-over-year, from 34.3M to 40.6M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.